Pathogenesis of Helicobacter pylori infection

Current Opinion in Gastroenterology

Volumn 15, Issue 1, 1999, Pages 66-71

  Wilson, Keith T ^a   Fantry, George T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOTOXIN; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UREASE; VIRULENCE FACTOR;

APOPTOSIS; BACTERIUM ADHERENCE; BLOOD GROUP LEWIS SYSTEM; CARDIA CARCINOMA; DIGESTIVE SYSTEM INFLAMMATION; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HELPER CELL; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM; TISSUE REPAIR;

EID: 0033056730     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199901000-00012     Document Type: Review

References (61)

1. 1 Ito A, Fujioka T, Kodama K, Nishizono A, Nasu M: Virulence-associated genes as markers of strain diversity in Helicobacter pylori infection. J Gastroenterol Hepatol 1997, 12:666-669.
2. 2 Orsini B, Ciancio G, Surrenti E, Macri G, Biagini MR, Milani S, Surrenti C: Serologic detection of CagA positive Helicobacter pylori infection in a northern Italian population: its association with peptic ulcer disease. Helicobacter 1998, 3:15-20.
3. 3 Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle PR, Stremmel W: Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol 1998, 36:944-948.
4. 4 van Doom LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de Boer W, Quint W: Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998, 115:58-66.
5. 5 Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF: Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol 1998, 51:55-61.
6. 6 Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J: Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997, 41:442-451.
7. 7 Figura N, Vindigni C, Covacci A, Presenti L, Burroni D, Vernillo R, et al.: cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage. Gut 1998, 42:772-778.
8. 8 Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, et al.: Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol 1998, 93:375-379.
9. 9 Yahiro K, Niidome T, Hatakeyama T, Aoyagi H, Kurazono H, Padilla PI, et al.: Helicobacter pylori vacuolating cytotoxin binds to the 140-kDa protein in human gastric cancer cell lines, AZ-521 and AGS. Biochem Biophys Res Commun 1997, 238:629-632.
10. 10 Massari P, Manetti R, Burroni D, Nuti S, Norais N, Rappuoli R, Telford JL: Binding of the Helicobacter pylori vacuolating cytotoxin to target cells. Infect Immun 1998, 66:3981-3984.
11. 11 Molinari M, Salio M, Galli C, Norais N, Rappuoli R, Lanzavecchia A, Montecucco C: Selective inhibition of li-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998, 187:135-140.
12. 12 Rudnicka W, Covacci A, Wadstrom T, Chmiela M: A recombinant fragment of Helicobacter pylori CagA affects proliferation of human cells. J Physiol Pharmacol 1998, 49:111-119.
13. 13 Scott DR, Weeks D, Hong C, Postius S, Melchers K, Sachs G: The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 1998, 114:58-70.
14. 14 Ermak TH, Ding R, Ekstein B, Hill J, Myers GA, Lee CK, et al.: Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology 1997, 113:1118-1128.
15. 15 Makristathis A, Rokita E, Labigne A, Willinger B, Rotter ML, Hirschl AM: Highly significant role of Helicobacter pylori urease in phagocytosis and production of oxygen metabolites by human granulocytes. J Infect Dis 1998, 177:803-806.
16. 16 Wilson KT, Ramanujam KS, Mobley HLT, Musselman RF, James SP, Meltzer SJ: Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 1996, 111:1524-1533.
17. 17 Ogawa T, Suda Y, Kashihara W, Hayashi T, Shimoyama T, Kusumoto S, Tamura T: Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506). Vaccine 1997, 15:1598-1605.
18. 18 Yokota S, Amano K, Hayashi S, Kubota T, Fujii N, Yokochi T: Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide. Infect Immun 1998, 66:3006-3011.
19. 19 Yamaoka Y, Kodama T, Graham DY, Kashima K: Search for putative virulence factors of Helicobacter pylori: the low-molecular-weight (33-35 K) antigen. Dig Dis Sci 1998, 43:1482-1487.
20. 20 Monteiro MA, Chan KH, Rasko DA, Taylor DE, Zheng PY, Appelmelk BJ, et al.: Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides: molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J Biol Chem 1998, 273:11533-11543.
21. 21 Wirth HP, Yang M, Peek Jr RM, Tham KT, Blaser MJ: Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 1997, 113:1091-1098.
22. b receptor for Helicobacter pylori in their gastric epithelium had increased attachment of H. pylori after inoculation, production of autoantibodies to Lewis antigens on both the bacteria and parietal cells, and increased gastritis and parietal cell loss.
23. 23 Clyne M, Drumm B: Absence of effect of Lewis A and Lewis B expression on adherence of Helicobacter pylori to human gastric cells. Gastroenterology 1997, 113:72-80.
24. 24 Faller G, Steininger H, Appelmelk B, Kirchner T: Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis. J Clin Pathol 1998, 51:244-245.
25. 25 Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, et al.: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377. The adherence of Helicobacter pylori to gastric epithelium was directly linked to a specific bacterial adhesin, BabA, which was associated with the cag pathogenicity island.
26. 26 Namavar F, Sparrius M, Veerman EC, Appelmelk BJ, Vandenbroucke-Grauls CM: Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect Immun 1998, 66:444-447.
27. 27 Byrd JC, Yan P, Sternberg L, Yunker CK, Scheiman JM, Bresalier RS: Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology 1997, 113:455-464.
28. 28 Munzenmaier A, Lange C, Glocker E, Covacci A, Moran A, Bereswill S, et al.: A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol 1997, 159:6140-6147.
29. 29 Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, Ohmoto Y, et al.: Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 1997, 65:3218-3224.
30. 30 Sharma SA, Tummuru MK, Blaser MJ, Kerr LD: Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 1998, 160:2401-2407. cagA+ strains were reported to induce increased binding activity of the transcription factor NF-κB to the IL-8 promoter and hence increased IL-8 gene expression. NF-κb mediated IL-8 transcription is suggested as a mechanism for the increased gastric inflammation that occurs with infection with cagA+ Helicobacter pylori strains.
31. 31 Glocker E, Lange C, Covacci A, Bereswill S, Kist M, Pahl HL: Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun 1998, 66:2346-2348.
32. 32 Beales IL, Calam J: Stimulation of IL-8 production in human gastric epithelial cells by Helicobacter pylori, IL-1 beta and TNF-alpha requires tyrosine kinase activity, but not protein kinase C. Cytokine 1997, 9:514-520.
33. 33 Segal ED, Lange C, Covacci A, Tompkins LS, Falkow S: Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A 1997, 94:7595-7599. This group has previously demonstrated that adherence of Helicobacter pylori to gastric epithelial cells is associated with attaching and effacing lesions, cytoskeletel rearrangements, and tyrosine phosphorylantion of host cell proteins similar to those occuring with enteropathogenic Esherichia coli. In this report, mutations in cag pathogenicity island genes are shown to abolish tyrosine phosphorylation and IL-8 synthesis but not cytoskeletal rearrangements. In addition a tyrosine phosphorylation-independent pathway of IL-8 production was identified.
34. 34 Pai R, Wyle FA, Cover TL, Itani RM, Domek MJ, Tarnawski AS: Helicobacter pylori culture supernatant interferes with epidermal growth factor-activated signal transduction in human gastric KATO III cells. Am J Pathol 1998, 152:1617-1624.
35. 35 Romano M, Ricci V, Di Popolo A, Sommi P, Del Vecchio Blanco C, Bruni CB, et al.: Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest 1998, 101:1604-1613. EGF and related growth factors are important in gastric mucosal cytoprotection and healing. In this study, Helicobacter pylori suspensions or culture supernatants were found to increase gene expression of amphiregulin and heparin-binding EGF-like growth factor. However, epithelial cell growth stimulation by these proteins was abolished by H. pylori culture filtrates. This inhibitory effect was independent of effects on the EGF receptor. The ability of H. pylori to block the effects of EGF-related growth factors may have a central role in H. pylori-induced mucosal injury.
36. 36 Terres AM, Pajares JM, Hopkins AM, Murphy A, Moran A, Baird AW, Kelleher D: Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect Immun 1998, 66:2943-2950. In this in vitro study, H. pylori sonicates were shown to decrease epithelial permeability in monolayers of intestinal epithelial cells. This alteration in barrier function may represent a mechanism by which H. pylori antigens can reach the gastric lamina propria.
37. 37 Chen G, Sordillo EM, Ramey WG, Reidy J, Holt PR, Krajewski S, et al.: Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of BAK. Biochem Biophys Res Commun 1997, 239:626-632. This study demonstrated that Helicobacter pylori induces apoptosis in a gastric epithelial cell line (AGS cells) in a concentration-dependent manner. This induction required bacterial-epithelial cell contact and appeared to also be dependent on expression of the Bcl-2 family protein Bak. Increased expression of Bak was also demonstrated in the epithelial cells in the superficial two thirds of gastric glands of H. pylori-infected human gastric tissue.
38. 38 Wagner S, Beil W, Westermann J, Logan RP, Bock CT, Trautwein C, et al.: Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 1997, 113:1836-1847.
39. 39 Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM: Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997, 151:1695-1703.
40. 40 Fan X, Crowe SE, Behar S, Gunasena H, Ye G, Haeberle H, et al.: The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J Exp Med 1998, 187:1659-1669. This study demonstrates that Helicobacter pylori-stimulated apoptosis may occur by H. pylori binding to class II MHC molecules on gastric epithelial cells and subsequent signaling events.
41. 41 Bamford KB, Fan X, Crowe SE, Leary JF, Gourfey WK, Luthra GK, et al.: Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998, 114:482-492. This study assessed the human gastric T cell responses to Helicobacter pylori. Increased CD4+ and CD8+ T cells were increased in the mucosa during infection. Freshly isolated gastric T cells expressed interferon-γ and IL-2 and little IL-4 or IL-5, consistent with a Th1-predominant T-cell response.
42. 42 D'Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, et al.: Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997, 27:1751-1755.
43. 43 Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaatari F, et al.: Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 1997, 65:4229-4235. In gastric biopsy specimens, no differences in expression of IL-10 and IL-12 were observed between tissues infected or uninfected with Helicobacter pylori. However, stimulation of peripheral blood mononuclear cells with H. pylori demonstrated that live H. pylori induced much greater increases of IL-12 than of IL-10. Killed H. pylori stimulated significantly higher levels of IL-10 than did live bacteria. These results support the concept of a Th1-predominant response to live bacteria, because IL-12 selects for Th1 cells and stimulates interferon-γ production, and also suggest that killed preparations or other components used in oral vaccines may be useful in inducing Th2 responses.
44. 44 Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ: Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 1997, 113:1848-1857. This study provides evidence that in the murine Helicobacter felis gastritis model, Th1 responses are primarily responsible for the inflammatory response and deficiency of Th2 responses results in inability to eliminate the bacteria. IL-4 knock-out mice, deficient in Th2 effector function, had greater gastric bacterial colonization than wild-type mice, and adoptive transfer of Th2 cells into normal mice significantly reduced bacterial load. Transfer of Th1 cells had no effect on bacterial load but increased the severity of inflammation.
45. 45 Jung HC, Kim JM, Song IS, Kim CY: Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J Gastroenterol Hepatol 1997, 12:473-480.
46. 46 Kusugami K, Ando T, Ohsuga M, Imada A, Shinoda M, Konagaya T, et al.: Mucosal chemokine activity in Helicobacter pylori infection. J Clin Gastroenterol 1997, 25(suppl 1):S203-S210.
47. 47 Suzuki H, Mori M, Sakaguchi AA, Suzuki M, Miura S, Ishii H: Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease. J Gastroenterol Hepatol 1998, 13:516-520.
48. 48 Watanabe N, Shimada T, Ohtsuka Y, Hiraishi H, Terano A: Proinflammatory cytokines and Helicobacter pylori stimulate CC-chemokine expression in gastric epithelial cells. J Physiol Pharmacol 1997, 48:405-413.
49. 49 Drake IM, Mapstone NP, Schorah CJ, White KL, Chalmers DM, Dixon MF, Axon AT: Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori-associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication. Gut 1998, 42:768-771.
50. 50 Nagata K, Yu H, Nishikawa M, Kashiba M, Nakamura A, Sato EF, et al.: Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism. J Biol Chem 1998, 273:14071-14073.
51. 51 Brzozowski T, Konturek PC, Sliwowski Z, Drozdowicz D, Pajdo R, Stachura J, et al.: Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide. J Physiol Pharmacol 1997, 48:699-717.
52. 52 Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997, 112:1386-1397.
53. 53 Ferrero RL, Thiberge JM, Huerre M, Labigne A: Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun 1998, 66:1349-1355.
54. 54 Manetti R, Massari P, Marchetti M, Magagnoli C, Nuti S, Lupetti P, et al.: Detoxification of the Helicobacter pylori cytotoxin. Infect Immun 1997, 65:4615-4619.
55. 55 Li H, Kalies I, Mellgard B, Helander HF: A rat model of chronic Helicobacter pylori infection: studies of epithelial cell turnover and gastric ulcer healing. Scand J Gastroenterol 1998, 33:370-378.
56. 56 Fox JG, Dangler CA, Whary MT, Edelman W, Kucherlapati R, Wang TC: Mice carrying a truncated Apc gene have diminished gastric epithelial proliferation, gastric inflammation, and humoral immunity in response to Helicobacter felis infection. Cancer Res 1997, 57:3972-3978.
57. 57 Sakagami T, Vella J, Dixon MF, O'Rourke J, Radcliff F, Sutton P, et al.: The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis. Infect Immun 1997, 65:3310-3316.
58. 58 Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Easley K, Richter JE: Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998, 114:633-639.
59. 59 Varanasi RV, Fantry GT, Wilson KT: Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998, 3:188-193.
60. 60 Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, et al.: The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998, 115:50-57. This is a prospective study of 153 patients with GERD or its complications assessing Helicobacter pylori and cagA status by histology and serology. The prevalence of cagA-positive strains was significantly lower in patients with severe complications of GERD. Therefore, cagA-positive H. pylori infection may protect against the development of reflux complications including Barrett's-associated dysplasia and cancer.
61. 61 Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al.: An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998, 58:588-590. Serum samples in patients with esophageal cancer, gastric cardia adenocarcinoma, and noncardia gastric adenocarcinoma were analyzed for antibodies to Helicobacter pylori and to recombinant fragments of CagA. Infection with cagA+ H. pylori strains was found to be associated with a reduced risk of esophageal and gastric cardia cancers. These findings suggest that the declining prevalence of H. pylori infection may be associated with the increased incidence of esophageal and gastric cardia cancer.